DigestRedComo funciona
Red
/
Empresas
St
No verificado

Stoke Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

47 Comunicados de prensa

Ver todos los comunicados de prensa
16/01/2026
Salud
Biotecnología
Ciencia
Sanidad
Farmacéutica
Mercado de valores
Finanzas
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
11/01/2026
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Web y redes sociales
Eventos
Industria
Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
06/01/2026
Eventos
Web y redes sociales
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Stoke Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
16/12/2025
Mercado de valores
Finanzas
Ciencia
Biotecnología
Sanidad
Salud
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
05/12/2025
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Eventos
Ferias y Congresos
Stoke Therapeutics and Biogen Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
01/12/2025
Ciencia
Infancia
Medicina - Varios
Biotecnología
Salud
Ir de compras
Farmacéutica
Eventos
Ferias y Congresos
Stoke Therapeutics and Biogen Announce Presentations at the 2025 American Epilepsy Society Annual Meeting
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
18/11/2025
Finanzas
Biotecnología
Farmacéutica
Salud
Sanidad
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
17/11/2025
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Stoke Therapeutics and Biogen Announce Publication of Two-Year Natural History Data Demonstrating the Severity of Dravet Syndrome, Including Frequent Seizures and Significant Cognitive and Behavioral Impairments
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
05/11/2025
Eventos
Web y redes sociales
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Stoke Therapeutics to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0
04/11/2025
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Web y redes sociales
Telefonía
Mercado de valores
Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Fuente
Stoke Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0